新诊断晚期卵巢癌新辅助化疗的价值：欧洲视角 - Suppr

Value of Neoadjuvant Chemotherapy for Newly Diagnosed Advanced Ovarian Cancer: A European Perspective.

作者信息

Fotopoulou Christina, Sehouli Jalid, Aletti Giovanni, Harter Philipp, Mahner Sven, Querleu Denis, Chiva Luis, Gabra Hani, Colombo Nicoletta, du Bois Andreas

机构信息

Christina Fotopoulou, Imperial College London, London, United Kingdom; Jalid Sehouli, Charité Medical University of Berlin, Berlin, Germany; Giovanni Aletti, European Institute of Oncology, Milan, Italy; Philipp Harter, Kliniken Essen Mitte, Essen, Germany; Sven Mahner, Ludwig-Maximilians-University, Munich, Germany; Denis Querleu, Institut Bergonié, Bordeaux, France; Luis Chiva, Clínica Universidad de Navarra, Navarra, Spain; Hani Gabra, Imperial College London, London, United Kingdom; Nicoletta Colombo, European Institute of Oncology, Milan, Italy; and Andreas du Bois, Kliniken Essen Mitte, Essen, Germany.

出版信息

J Clin Oncol. 2017 Feb 20;35(6):587-590. doi: 10.1200/JCO.2016.71.0723. Epub 2017 Jan 9.

DOI:10.1200/JCO.2016.71.0723

PMID:28068169

Abstract

摘要

相似文献

Value of Neoadjuvant Chemotherapy for Newly Diagnosed Advanced Ovarian Cancer: A European Perspective.新诊断晚期卵巢癌新辅助化疗的价值：欧洲视角

J Clin Oncol. 2017 Feb 20;35(6):587-590. doi: 10.1200/JCO.2016.71.0723. Epub 2017 Jan 9.

Neoadjuvant Chemotherapy Increases R0 Cytoreduction Rate But Does Not Improve Final Outcome in Advanced Epithelial Ovarian Cancer.新辅助化疗可提高晚期上皮性卵巢癌的R0细胞减灭率，但不能改善最终结局。

Ann Surg Oncol. 2017 May;24(5):1330-1335. doi: 10.1245/s10434-016-5704-3. Epub 2016 Dec 19.

Oncologic Concerns regarding Laparoscopic Cytoreductive Surgery in Patients with Advanced Ovarian Cancer Submitted to Neoadjuvant Chemotherapy.关于接受新辅助化疗的晚期卵巢癌患者腹腔镜肿瘤细胞减灭术的肿瘤学问题

Oncology. 2015;89(3):159-66. doi: 10.1159/000381462. Epub 2015 May 1.

Cost-effectiveness of laparoscopy as diagnostic tool before primary cytoreductive surgery in ovarian cancer.腹腔镜在卵巢癌初次细胞减灭术前作为诊断工具的成本效益。

Gynecol Oncol. 2017 Sep;146(3):449-456. doi: 10.1016/j.ygyno.2017.06.019. Epub 2017 Jun 20.

A Comparison of Survival Outcomes in Advanced Serous Ovarian Cancer Patients Treated With Primary Debulking Surgery Versus Neoadjuvant Chemotherapy.原发性肿瘤细胞减灭术与新辅助化疗治疗晚期浆液性卵巢癌患者的生存结果比较

Int J Gynecol Cancer. 2017 May;27(4):668-674. doi: 10.1097/IGC.0000000000000946.

Impact of Pelvic and Para-aortic Lymphadenectomy in Advanced Ovarian Cancer After Neoadjuvant Chemotherapy.新辅助化疗后盆腔及腹主动脉旁淋巴结清扫术对晚期卵巢癌的影响

Anticancer Res. 2015 Oct;35(10):5503-9.

Surgical complexity score and role of laparoscopy in women with advanced ovarian cancer treated with neoadjuvant chemotherapy.新辅助化疗治疗晚期卵巢癌女性的手术复杂程度评分和腹腔镜的作用。

Gynecol Oncol. 2019 Mar;152(3):554-559. doi: 10.1016/j.ygyno.2018.12.011. Epub 2018 Dec 14.

Point/Counterpoint: Primary Debulking Surgery vs Neoadjuvant Chemotherapy for Newly Diagnosed Advanced Ovarian Cancer.针锋相对：原发性肿瘤减灭术与新辅助化疗治疗新诊断的晚期卵巢癌

Oncology (Williston Park). 2017 Jun 15;31(6):453-58, 460-61.

[Ⅱ.Comparison between Upfront Primary Debulking Surgery and Interval Debulking Surgery Following Neoadjuvant Chemotherapy for Primary Treatment of Ovarian Cancer].[Ⅱ. 卵巢癌初始治疗中，新辅助化疗后直接进行的初次肿瘤细胞减灭术与间隔性肿瘤细胞减灭术的比较]

Gan To Kagaku Ryoho. 2019 Feb;46(2):236-239.

Cytoreduction vs. neoadjuvant chemotherapy for ovarian cancer.卵巢癌的细胞减灭术与新辅助化疗对比

Gynecol Oncol. 2008 Dec;111(3):391-9. doi: 10.1016/j.ygyno.2008.07.058.

引用本文的文献

Clinical characteristics and predictors of survival in 284 patients with recurrent epithelial ovarian cancer: a large-scale retrospective analysis.284例复发性上皮性卵巢癌患者的临床特征及生存预测因素：一项大规模回顾性分析

Ann Med Surg (Lond). 2025 Apr 15;87(6):3107-3112. doi: 10.1097/MS9.0000000000003297. eCollection 2025 Jun.

Novel Models of Epithelial Ovarian Cancer: The Future of Biomarker and Therapeutic Research.上皮性卵巢癌的新型模型：生物标志物与治疗研究的未来

Front Oncol. 2022 Mar 25;12:837233. doi: 10.3389/fonc.2022.837233. eCollection 2022.

Comparison of Neoadjuvant Chemotherapy Efficiency in Advanced Ovarian Cancer Patients Treated With Paclitaxel Plus Carboplatin and Intraperitoneal Bevacizumab vs. Paclitaxel With Carboplatin.紫杉醇联合卡铂与腹腔注射贝伐单抗对比紫杉醇联合卡铂治疗晚期卵巢癌患者的新辅助化疗疗效比较

Front Med (Lausanne). 2022 Mar 9;9:807377. doi: 10.3389/fmed.2022.807377. eCollection 2022.

Feature Selection is Critical for 2-Year Prognosis in Advanced Stage High Grade Serous Ovarian Cancer by Using Machine Learning.使用机器学习对晚期高级别浆液性卵巢癌进行 2 年预后的特征选择至关重要。

Cancer Control. 2021 Jan-Dec;28:10732748211044678. doi: 10.1177/10732748211044678.

Survival impact of bowel resection at the time of interval cytoreductive surgery for advanced ovarian cancer.晚期卵巢癌间歇性肿瘤细胞减灭术时肠切除术对生存的影响。

Gynecol Oncol Rep. 2021 Sep 25;38:100870. doi: 10.1016/j.gore.2021.100870. eCollection 2021 Nov.

How to predict treatment failure in frail patients with advanced epithelial ovarian cancer: strategies to personalize surgical effort.如何预测晚期上皮性卵巢癌体弱患者的治疗失败：个性化手术努力的策略

J Gynecol Oncol. 2020 Jan;31(1):e26. doi: 10.3802/jgo.2020.31.e26. Epub 2019 Nov 1.

Maximal-Effort Cytoreductive Surgery for Ovarian Cancer Patients with a High Tumor Burden: Variations in Practice and Impact on Outcome.高肿瘤负荷的卵巢癌患者的最大努力细胞减灭术：实践中的差异及其对结局的影响。

Ann Surg Oncol. 2019 Sep;26(9):2943-2951. doi: 10.1245/s10434-019-07516-3. Epub 2019 Jun 26.

Impact of Radicality Versus Timing of Surgery in Patients with Advanced Ovarian Cancer (Stage III C) Undergoing CRS and HIPEC-a Retrospective Study by INDEPSO.根治性手术与手术时机对晚期卵巢癌（ⅢC期）患者接受细胞减灭术和腹腔热灌注化疗的影响——由INDEPSO开展的一项回顾性研究

Indian J Surg Oncol. 2019 Feb;10(Suppl 1):57-64. doi: 10.1007/s13193-019-00875-z. Epub 2019 Jan 16.

Bowel resection rate but not bowel related morbidity is decreased after interval debulking surgery compared to primary surgery in patents with stage IIIC-IV ovarian cancer.与初次手术相比，在 IIIC-IV 期卵巢癌患者中，间隔减瘤手术后的肠道切除率降低，但肠道相关发病率并未降低。

J Gynecol Oncol. 2019 Mar;30(2):e25. doi: 10.3802/jgo.2019.30.e25. Epub 2018 Nov 30.

A predictive score for optimal cytoreduction at interval debulking surgery in epithelial ovarian cancer: a two- centers experience.上皮性卵巢癌间隔性肿瘤细胞减灭术的最佳减瘤预测评分：两中心经验。

J Ovarian Res. 2018 May 30;11(1):42. doi: 10.1186/s13048-018-0415-y.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Value of Neoadjuvant Chemotherapy for Newly Diagnosed Advanced Ovarian Cancer: A European Perspective.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献